Novavax Researcher Says No Chance Of A 'Shortcut' In Vaccine Safety
Podcast |
KPCC News
Publisher |
89.3 KPCC
Media Type |
audio
Categories Via RSS |
News & Politics
Publication Date |
Sep 26, 2020
Episode Duration |
00:05:23
Vaccine maker Novavax is starting a large coronavirus vaccine trial in the U.K. Gregory Glenn, the company's president of research and development, talks with NPR about how vaccines are tested.

This episode currently has no reviews.

Submit Review
This episode could use a review!

This episode could use a review! Have anything to say about it? Share your thoughts using the button below.

Submit Review